José Federico
Díaz González
Catedrático de Universidad
Hospital de Gran Canaria Dr. Negrin
Las Palmas de Gran Canaria, EspañaHospital de Gran Canaria Dr. Negrin -ko ikertzaileekin lankidetzan egindako argitalpenak (13)
2024
-
Real-world persistence of initial targeted therapy strategy in monotherapy versus combination therapy in patients with chronic inflammatory arthritis
European Journal of Clinical Investigation, Vol. 54, Núm. 2
-
The complement system is linked to insulin resistance in patients with systemic lupus erythematosus
Clinical and experimental rheumatology, Vol. 42, Núm. 1, pp. 115-121
2023
-
Full characterization of the three pathways of the complement system in patients with systemic lupus erythematosus
Frontiers in Immunology, Vol. 14
-
HDL Cholesterol Efflux and the Complement System Are Linked in Systemic Lupus Erythematosus
Journal of Clinical Medicine, Vol. 12, Núm. 16
-
Long-term retention of golimumab treatment in clinical practice in a large cohort of patients with rheumatoid arthritis, axial spondyloarthritis and psoriatic arthritis
Musculoskeletal Care, Vol. 21, Núm. 1, pp. 189-197
2021
-
Association of Gender, Diagnosis, and Obesity With Retention Rate of Secukinumab in Spondyloarthropathies: Results Form a Multicenter Real-World Study
Frontiers in Medicine, Vol. 8
-
Changes in the use patterns of bDMARDs in patients with rheumatic diseases over the past 13 years
Scientific Reports, Vol. 11, Núm. 1
-
Differences in Capacity of High-Density Lipoprotein Cholesterol Efflux Between Patients With Systemic Lupus Erythematosus and Rheumatoid Arthritis
Arthritis Care and Research, Vol. 73, Núm. 11, pp. 1590-1596
-
Role of targeted therapies in rheumatic patients on COVID-19 outcomes: Results from the COVIDSER study
RMD Open, Vol. 7, Núm. 3
2020
-
Impaired HDL cholesterol efflux capacity in systemic lupus erythematosus patients is related to subclinical carotid atherosclerosis
Rheumatology (Oxford, England), Vol. 59, Núm. 10, pp. 2847-2856
2019
-
Objectives and methodology of BIOBADASER phase III
Reumatologia Clinica, Vol. 15, Núm. 4, pp. 229-236
2018
-
Persistence and adverse events of biological treatment in adult patients with juvenile idiopathic arthritis: Results from BIOBADASER
Arthritis Research and Therapy, Vol. 20, Núm. 1